65 of 284 telehealth providers advertise less than you actually pay.
On TeleWellnessMD’s own pricing, tirzepatide advertises at $279.95/mo and recurs at $679.95/mo. Read the TeleWellnessMD review.
We read each provider’s own pricing page, then compare the headline number with what recurs once a promotion ends or a mandatory fee lands.
What we found
Every figure below comes from the providers' own pricing pages — the same prices each review is built on.
Providers graded
284
Each one read from its own pricing page and FAQ.
Priced plans with a gap
156 of 1,205
Plans where the advertised number is lower than what actually recurs, across 65 of 284 providers.
That gap, over twelve months
$4,800
TeleWellnessMD’s tirzepatide advertises $279.95/mo and actually recurs at $679.95/mo. Held twelve months, that one difference alone is $4,800.
Prices checked
1,571
Each price carries the month we read it.
The biggest advertised-vs-actual gaps
156 of the 1,205 priced plans we checked, across 65 of 284 providers, advertise a lower monthly figure than the one that actually recurs. The 8 widest are below — teal is the advertised price, the lighter segment is what gets added.
tirzepatide
tirzepatide
tirzepatide
semaglutide
semaglutide
tirzepatide
semaglutide
semaglutide
Check any provider’s advertised price against what recurs — all 284 in the true-cost calculator →
The market, at a glance
The same figures every review is built from, and the three biggest advertised-vs-actual gaps we've found — read the review before you decide it's worth the catch.
By the numbers
- Providers graded
- 284
- Plans priced
- 1,205
- Prices checked
- 1,571
- Largest advertised-vs-actual gap
- +$400/mo
- Providers with a gap found
- 65
- Publish a state list
- 28 of 284
| Provider | Grade | Advertises | What recurs | Gap |
|---|---|---|---|---|
| TeleWellnessMD | CCaveat | $279.95/mo | $679.95/mo | +$400/mo |
| Zealthy | CCaveat | $216/mo | $449/mo | +$233/mo |
| Direct Meds | CCaveat | $199/mo | $399/mo | +$200/mo |
The 3 largest gaps in the full chart above, one row per provider.
What we hold, state by state
Almost none of the providers we grade publish which states they operate in, so we can’t honestly count providers per state — and we don’t color a map by “providers available here.” Instead this shows which states we’ve built a sourced guide for, and how many independently dated facts back it. A blank tile means no guide yet, never no coverage.
Scroll sideways to see the whole map. →
Guides published — 51 of 51
- Colorado10 sourced facts
- Florida9 sourced facts
- Georgia9 sourced facts
- Iowa9 sourced facts
- Mississippi9 sourced facts
- North Dakota9 sourced facts
Show all 51 state guides
- Tennessee9 sourced facts
- West Virginia9 sourced facts
- Kansas8 sourced facts
- Louisiana8 sourced facts
- Nevada8 sourced facts
- Oklahoma8 sourced facts
- Rhode Island8 sourced facts
- Utah8 sourced facts
- Vermont8 sourced facts
- Arizona7 sourced facts
- Arkansas7 sourced facts
- District of Columbia7 sourced facts
- Idaho7 sourced facts
- Illinois7 sourced facts
- Maryland7 sourced facts
- Massachusetts7 sourced facts
- Missouri7 sourced facts
- New Mexico7 sourced facts
- Pennsylvania7 sourced facts
- South Dakota7 sourced facts
- Virginia7 sourced facts
- Washington7 sourced facts
- Alabama6 sourced facts
- California6 sourced facts
- Connecticut6 sourced facts
- Hawaii6 sourced facts
- Indiana6 sourced facts
- Kentucky6 sourced facts
- Maine6 sourced facts
- Minnesota6 sourced facts
- Nebraska6 sourced facts
- New Jersey6 sourced facts
- New York6 sourced facts
- North Carolina6 sourced facts
- Oregon6 sourced facts
- Texas6 sourced facts
- Wisconsin6 sourced facts
- Wyoming6 sourced facts
- Alaska5 sourced facts
- Michigan5 sourced facts
- Montana5 sourced facts
- New Hampshire5 sourced facts
- South Carolina5 sourced facts
- Delaware4 sourced facts
- Ohio4 sourced facts
51 of 51 — the 50 states and the District of Columbia — have a guide we’ve built from primary documents — Medicaid bulletins, enacted budgets, board minutes — each one dated and quoted, never a claim about which companies operate there. The shading is how much we hold, not how big a state is. See every state guide.
GLP-1 plans, priced with fees included
Prices are only half the question. We also read the evidence behind what these companies sell — what the trials actually show for the peptides on their menus, and what the FDA has and has not approved — in our research write-ups, and we track what each state has decided about coverage state by state.
- TirzepatideCompounded tirzepatide online: providers and prices compared
- SemaglutideCompounded semaglutide online: providers and prices compared
See all 284 graded providers →
Some providers pay us a commission when you sign up through our links, at no extra cost to you. Providers we work with may appear first. How we’re funded.
Read the evidence behind the prices
Sourced write-ups on what these companies sell, what the FDA has and has not approved, and what coverage and cancellation actually look like.
- Buyer guideWhat a GLP-1 costs in cash, and why nobody can name the cheapest
- Compounded supplyWhere compounded semaglutide stands with the FDA, with the dates
- Product evidenceOral GLP-1s: two approved weight-loss pills, and no oral tirzepatide
- Access guidePrior authorization for a GLP-1, and what a denial actually turns on
- Access guideState Medicaid and GLP-1s: the same federal permission, forty-two different answers
- Buyer guideWhat a telehealth membership actually buys
- ReferenceEvery peptide on a telehealth menu, and where the FDA actually put it
- Peptide evidenceBPC-157: what the FDA actually said, and what the trials show